Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Single-Arm, Open-Label Study of Brentuximab Vedotin as Front-Line Therapy of Hodgkin Lymphoma (HL) in Adults Age 60 and Above
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.